Does switching the bacillus Calmette-Guerin strain affect clinical outcome in patients with recurrent non–muscle-invasive bladder cancer after initial bacillus Calmette-Guerin therapy?
Urologic Oncology: Seminars and Original Investigations | Mar 15, 2018
The role of neural precursor cell-expressed developmentally down-regulated protein 9 in predicting bacillus Calmette-Guerin response in nonmuscle invasive bladder cancer
Urologic Oncology: Seminars and Original Investigations | Mar 13, 2018
Most read this week